Loading the security page…
A security analysis is not yet prepared for this market.
Based on the last 12 months of reports, through 30 June 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Immunic, Inc. (IMUX) is a company in the Health care sector; its shares trade on Nasdaq.
The price of Immunic, Inc. (IMUX) on November 12, 2026 is 7.97 $, −1.85 % on the day. Over 52 weeks the stock traded between 5.06 $ and 17.43 $; the price now sits 24 % of the way up that range. Over the past year the price changed by +2.57 %. Market capitalization is 127.97 million $, rank 218 among 384 stocks of the same industry with a known capitalization.
Immunic, Inc. trades on Nasdaq under the ticker IMUX. The company belongs to the Health care sector. The trading history on this page starts on 22 August 2016.
Over the past 52 weeks IMUX has traded between 5.06 $ and 17.43 $. As of 12 November 2026 the price stood 22.11% of the way from the 52-week low to the high.
Over one year IMUX shares rose 2.57%; over six months they fell 38.40%. Volatility over 90 days is 69.52%. Dividends are not included: this is price change only, as of 12 November 2026.
The company reported a loss over the last four quarters, so a price-to-earnings ratio is not calculated. Price to book is 1.0, below the sector median of 2.4. Calculated from reports for the period ending 30 June 2026.
IMUX has a return on equity of −87.45%, below the sector median of −40.58%. Return on assets is −70.09%, below the sector median of −30.08%.